Mapping of 5‐HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies

The anatomic distribution of serotonin 5‐HT2A receptors visualized with [3H]MDL100,907 and of their mRNA detected by in situ hybridization were studied in monkey brain. Both autoradiographic patterns of signal showed heterogeneous distributions and were in general in good agreement in the majority of brain regions. In most neocortical areas, [3H]MDL100,907 presented a four‐banded pattern with layers I and III‐IV more intensely labeled and layers II and V‐VI showing weaker labeling. 5‐HT2A receptor mRNA was detected in layers III and IV, and in some cases also in layers II and V. In intra‐ and extra‐calcarine areas of striate cortex a five‐banded pattern was distinguished, with layers III and IVc‐V showing the highest densities of [3H]MDL100,907 labeling. These two areas showed the highest neocortical hybridization signal. An unexpected finding was the presence of low densities of [3H]MDL100,907 labeling and 5‐HT2A receptor mRNA in choroid plexus. Comparison of the distribution of [3H]MDL100,907 and [3H]ketanserin binding sites in monkey brain regions with high nonspecific [3H]ketanserin binding (caudate, putamen, substantia nigra, inferior olive) revealed specific binding of [3H]MDL100,907 with very low nonspecific binding. Some differences were noted between the distribution of [3H]MDL100,907‐labeled 5‐HT2A receptors in monkey brain and the previously reported distribution of these receptors in human brain: absence of striosome labeling in monkey striatum and different patterns of neocortical labeling. The present results provide the first detailed comparison of 5‐HT2A receptor and mRNA distribution in primate brain. The observed species differences in 5‐HT2A receptor distribution should be considered when extrapolating results among different species. J. Comp. Neurol. 429:571–589, 2001. © 2000 Wiley‐Liss, Inc.

[1]  J. Leysen,et al.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. , 1981, Life sciences.

[2]  C. Katona,et al.  Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment , 1994, Brain Research.

[3]  G. Aghajanian,et al.  Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist. , 1994, European journal of pharmacology.

[4]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[5]  M. Mikuni,et al.  Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration , 2000, Brain Research.

[6]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors , 1985, Brain Research.

[7]  P S Goldman-Rakic,et al.  Quantitative autoradiographic mapping of serotonin 5‐HT1 and 5‐HT2 receptors and uptake sites in the neocortex of the rhesus monkey , 1989, The Journal of comparative neurology.

[8]  J. Wettstein,et al.  Selectivity of action of typical and atypical antipsychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  M. Nöthen,et al.  Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene , 1996, The Lancet.

[10]  J. Palacios,et al.  Human striosomes are enriched in 5‐HT2A receptors: autoradiographical visualization with [3H]MDL100,907, [125I](±)DOI and [3H]ketanserin , 1999, The European journal of neuroscience.

[11]  J. Palacios,et al.  Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.

[12]  H. Meltzer,et al.  Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens. , 1998, European journal of pharmacology.

[13]  J. Kehne,et al.  Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. , 1993, The Journal of pharmacology and experimental therapeutics.

[14]  H. Ladinsky,et al.  Comparative anatomical distribution of serotonin 1A, 1Dα and 2A receptor mRNAs in human brain postmorten , 1996 .

[15]  F. Blaney,et al.  5-HT2 receptor subtypes: a family re-united? , 1995, Trends in pharmacological sciences.

[16]  B. McEwen,et al.  Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.

[17]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[18]  C. J. Schmidt,et al.  Blockade of Striatal 5‐Hydroxytryptmine2 Receptors Reduces the Increase in Extracellullar Concentrations of Dopamine Produced by the Amphhetamine analogue 3,4‐Methylenedioxymethamphetamine , 1994, Journal of neurochemistry.

[19]  J. Kehne,et al.  Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. , 1996, The Journal of pharmacology and experimental therapeutics.

[20]  D. Morilak,et al.  Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain , 1993, Neuroscience.

[21]  M. Palkovits,et al.  5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala , 1993, Brain Research.

[22]  P. Goldman-Rakic,et al.  Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  S. Snyder,et al.  Neurotransmitter receptors in frontal cortex of schizophrenics. , 1979, Archives of general psychiatry.

[24]  Paul J. Harrison,et al.  The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain , 1995, Brain Research.

[25]  M. Molliver,et al.  Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex , 1988, Brain Research.

[26]  B. Mulsant,et al.  PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. , 1999, The American journal of psychiatry.

[27]  D. Wright,et al.  Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain , 1995, The Journal of comparative neurology.

[28]  L. Descarries,et al.  Cellular and subcellular distribution of the serotonin 5‐HT2A receptor in the central nervous system of adult rat , 1999, The Journal of comparative neurology.

[29]  M. Pompeiano,et al.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.

[30]  H. Meltzer The Role of Serotonin in Antipsychotic Drug Action , 1999, Neuropsychopharmacology.

[31]  P S Goldman-Rakic,et al.  Quantitative autoradiography of major neurotransmitter receptors in the monkey striate and extrastriate cortex , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  M. Karnovsky,et al.  A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES , 1964, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  G. Aghajanian,et al.  Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release , 1999, Brain Research.

[34]  L. JakabR,et al.  霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位 , 1998 .

[35]  M. Lidow,et al.  Adrenergic and serotonergic receptors in aged monkey neocortex , 1995, Neurobiology of Aging.

[36]  Paul J. Harrison,et al.  5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia , 1996, Neuropsychopharmacology.

[37]  R. Schreiber,et al.  (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. , 1995, The Journal of pharmacology and experimental therapeutics.

[38]  H. Ladinsky,et al.  Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain postmortem. , 1996, Brain Research. Molecular Brain Research.

[39]  D. Geschwind,et al.  Distribution of major neurotransmitter receptors in the motor and somatosensory cortex of the rhesus monkey , 1989, Neuroscience.

[40]  J. Kehne,et al.  The role of 5-HT2A receptors in antipsychotic activity. , 1995, Life sciences.

[41]  C. J. Schmidt,et al.  5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. , 1992, European journal of pharmacology.

[42]  V. Arango,et al.  Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.

[43]  A. Ravindran,et al.  Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. , 2000, American journal of medical genetics.

[44]  K. Lesch,et al.  Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter , 1999, Neuroscience Letters.

[45]  C. Halldin,et al.  PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[46]  J D Brodie,et al.  Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  M. Pompeiano,et al.  Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites , 1990, Brain Research.

[48]  L. Iversen,et al.  Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type , 1984, Neuroscience Letters.

[49]  B. Dean,et al.  Decreased frontal cortical serotonin2A receptors in schizophrenia , 1996, Schizophrenia Research.

[50]  J. Palacios,et al.  Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907 , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[51]  H. Yoneda,et al.  Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. , 1996, American journal of medical genetics.

[52]  S. Hamada,et al.  Localization of 5-HT2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken. , 1998, Brain research. Molecular brain research.

[53]  C. J. Schmidt,et al.  Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade. , 1996, The Journal of pharmacology and experimental therapeutics.

[54]  C. J. Schmidt,et al.  The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. , 1995, European journal of pharmacology.

[55]  B. Dean,et al.  Serotonin2 receptors and the serotonin transporter in the schizophrenic brain , 1995, Behavioural Brain Research.

[56]  F. Fonnum,et al.  Topography of cholinergic and substance P pathways in the habenulo-interpeduncular system of the rat. An immunocytochemical and microchemical approach , 1987, Neuroscience.

[57]  C. Bethea,et al.  Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. , 1999, Brain research. Molecular brain research.

[58]  R. Pearson,et al.  The Human Nervous System. Basic Elements of Structure and Function , 1967, The Yale Journal of Biology and Medicine.

[59]  Anat Biegon,et al.  Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide , 1990, Brain Research.

[60]  P S Goldman-Rakic,et al.  5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Palacios,et al.  [3H]MDL100,907 labels 5-HT2A serotonin receptors selectively in primate brain , 1998, Neuropharmacology.

[62]  G. Aghajanian,et al.  Serotonin Induces Excitatory Postsynaptic Potentials in Apical Dendrites of Neocortical Pyramidal Cells , 1997, Neuropharmacology.

[63]  R. Schreiber,et al.  Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. , 1994, European journal of pharmacology.

[64]  D. Graham,et al.  5HT2 receptors in dementia of the Alzheimer type: A quantitative autoradiographic study of frontal cortex and hippocampus , 1990 .

[65]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.